| Dr James Travis Burt, MD, FACS | |
|
1 Medical Park Blvd Ste 400e, Bristol, TN 37620-7431 | |
| (423) 844-5400 | |
| (423) 844-5434 |
| Full Name | Dr James Travis Burt |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 37 Years |
| Location | 1 Medical Park Blvd Ste 400e, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619983962 | NPI | - | NPPES |
| 3092743 | Medicaid | TN | |
| 9801401000 | Medicaid | WV | |
| 6101241 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 0101056734 (Virginia) | Secondary |
| 207T00000X | Neurological Surgery | 0000026843 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Champion Physical Therapy Llc Halls | 1355416306 | 241 |
| Highlands Neurosurgery Pc | 7012813835 | 7 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced its plans for 2010 aimed at advancing the clinical development of its high-value drug development pipeline and enhancing shareholder value.
Lawmakers are planning to pay for much of their plans to expand coverage to the uninsured by slowing Medicare spending by as much as $500 billion over 10 years, Long Island Newsday reports. Democrats say the only thing the cuts "take out of Medicare is waste" - in the words of Senate Majority Leader Harry Reid, - but Republicans who oppose the Democrat-led reform effort have warned that cuts will reduce services for seniors.
The aging baby boomers and subsequent generations will be looking to the food industry to provide products that can help them live longer, healthier and more active lives than previous generations, according to research presented at the Institute of Food Technologists' Wellness 12 meeting.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston have new insight as to why.
› Verified 4 days ago
| Entity Name | Highlands Neurosurgery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104830405 PECOS PAC ID: 7012813835 Enrollment ID: O20110829000191 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced its plans for 2010 aimed at advancing the clinical development of its high-value drug development pipeline and enhancing shareholder value.
Lawmakers are planning to pay for much of their plans to expand coverage to the uninsured by slowing Medicare spending by as much as $500 billion over 10 years, Long Island Newsday reports. Democrats say the only thing the cuts "take out of Medicare is waste" - in the words of Senate Majority Leader Harry Reid, - but Republicans who oppose the Democrat-led reform effort have warned that cuts will reduce services for seniors.
The aging baby boomers and subsequent generations will be looking to the food industry to provide products that can help them live longer, healthier and more active lives than previous generations, according to research presented at the Institute of Food Technologists' Wellness 12 meeting.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston have new insight as to why.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Travis Burt, MD, FACS 1 Medical Park Blvd Ste 400e, Bristol, TN 37620-7431 Ph: (423) 844-5400 | Dr James Travis Burt, MD, FACS 1 Medical Park Blvd Ste 400e, Bristol, TN 37620-7431 Ph: (423) 844-5400 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced its plans for 2010 aimed at advancing the clinical development of its high-value drug development pipeline and enhancing shareholder value.
Lawmakers are planning to pay for much of their plans to expand coverage to the uninsured by slowing Medicare spending by as much as $500 billion over 10 years, Long Island Newsday reports. Democrats say the only thing the cuts "take out of Medicare is waste" - in the words of Senate Majority Leader Harry Reid, - but Republicans who oppose the Democrat-led reform effort have warned that cuts will reduce services for seniors.
The aging baby boomers and subsequent generations will be looking to the food industry to provide products that can help them live longer, healthier and more active lives than previous generations, according to research presented at the Institute of Food Technologists' Wellness 12 meeting.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston have new insight as to why.
› Verified 4 days ago
Dr. Jody Benton Helms, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd Ste 400e, Bristol, TN 37620 Phone: 423-844-5400 | |
Dr. Jim Carroll Brasfield, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 320 Bristol Blvd W, Bristol, TN 37620 Phone: 423-844-6407 Fax: 423-793-7004 | |
Dr. Matthew William Wood Jr., M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Blvd, Suite 400 East, Bristol, TN 37620 Phone: 423-844-5400 Fax: 423-844-5434 | |
Dr. Robert Andrew Rice, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd Ste 400e, Bristol, TN 37620 Phone: 423-844-5400 Fax: 423-844-5434 |